View Entire Collection
By Clinical Topic
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
FRIDAY, Sept. 25 (HealthDay News) -- The U.S. Food and Drug Administration has issued a Public Health Alert to notify pharmacists and prescribers about the potential for dosing errors with oseltamivir (Tamiflu for Oral Suspension).
According to a Sept. 24 FDA news release, U.S. health care providers write prescriptions for most liquid medicines in milliliters or teaspoons. However, Tamiflu is dosed in milligrams, and the dosing dispenser that comes with the drug is marked only in milligrams. Consequently, the FDA has received reports of errors when dosing instructions given to patients do not match the dosing dispenser.
The agency is recommending that prescribers write doses in milligrams if the dosing dispenser with the drug is in milligrams and that pharmacists ensure that the units of measure on the dosing dispenser match those in the prescription instructions. In its Public Health Alert, the FDA provided specific considerations for Tamiflu dosing in children older than 1 year, as well as a chart showing recommended doses in both milligrams and milliliters.
According to the Public Health Alert, "prescribers should avoid prescribing Tamiflu oral suspension in teaspoons. This can lead to inaccurate dosing. If a prescription is written in teaspoons, the pharmacist should convert the volume to milliliters and ensure that an appropriate measuring device, such as an oral syringe calibrated in milliliters, is provided. The dosing dispenser packaged with the product should be discarded."
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top